Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick G Morris

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
Expert Review of Anticancer Therapy|December 7, 2013
Brain metastases in breast cancerHao-Wen Sim, Patrick G Morris, Sujata Patil, et al.
Future Oncology (London, England)|June 10, 2010
Dose-dense chemotherapy for breast cancer: what does the future hold?Patrick G Morris, Heather L McArthur, Clifford Hudis, et al.
Expert Opinion on Investigational Drugs|December 19, 2017
PI3K inhibition to overcome endocrine resistance in breast cancerNiamh M Keegan, Jack P Gleeson, Bryan T Hennessy, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|November 9, 2010
Bone scans, bisphosphonates, and a lack of acute changes within the mandiblePatrick G Morris, Clifford Hudis, Jorge Carrasquillo, et al.
Clinical Breast Cancer|September 14, 2016
Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast CancerKaren A Cadoo, Patrick G Morris, Elizabeth P Cowell, et al.
Irish Journal of Medical Science|May 22, 2020
Patient demographics and management challenges in an Irish symptomatic breast cancer unitZac L Coyne, Maeve Hennessy, Deirdre Duke, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 20, 2021
Prognostic factors influencing survival following re-resection for isocitrate dehydrogenase (IDH) -wildtype glioblastoma multiforme - Data from a national neuro-oncology registryMaeve A Hennessy, Zachary L Coyne, Philip J O'Halloran, et al.
Anti-Cancer Drugs|April 6, 2019
An uncommon complication of vertebroplasty: the role of anticoagulationNiamh O'Connor-Byrne, Caitriona Logan, Niamh Keegan, et al.
Cancer|September 3, 2011
Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancerAna P Kiess, Heather L McArthur, Kathleen Mahoney, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 16, 2008
Emergence of MRSA in positive blood cultures from patients with febrile neutropenia--a cause for concernPatrick G Morris, Tidi Hassan, Mairead McNamara, et al.
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
Expert Review of Anticancer Therapy|December 7, 2013
Brain metastases in breast cancerHao-Wen Sim, Patrick G Morris, Sujata Patil, et al.
Future Oncology (London, England)|June 10, 2010
Dose-dense chemotherapy for breast cancer: what does the future hold?Patrick G Morris, Heather L McArthur, Clifford Hudis, et al.
Expert Opinion on Investigational Drugs|December 19, 2017
PI3K inhibition to overcome endocrine resistance in breast cancerNiamh M Keegan, Jack P Gleeson, Bryan T Hennessy, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|November 9, 2010
Bone scans, bisphosphonates, and a lack of acute changes within the mandiblePatrick G Morris, Clifford Hudis, Jorge Carrasquillo, et al.
Clinical Breast Cancer|September 14, 2016
Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast CancerKaren A Cadoo, Patrick G Morris, Elizabeth P Cowell, et al.
Irish Journal of Medical Science|May 22, 2020
Patient demographics and management challenges in an Irish symptomatic breast cancer unitZac L Coyne, Maeve Hennessy, Deirdre Duke, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 20, 2021
Prognostic factors influencing survival following re-resection for isocitrate dehydrogenase (IDH) -wildtype glioblastoma multiforme - Data from a national neuro-oncology registryMaeve A Hennessy, Zachary L Coyne, Philip J O'Halloran, et al.
Anti-Cancer Drugs|April 6, 2019
An uncommon complication of vertebroplasty: the role of anticoagulationNiamh O'Connor-Byrne, Caitriona Logan, Niamh Keegan, et al.
Cancer|September 3, 2011
Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancerAna P Kiess, Heather L McArthur, Kathleen Mahoney, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 16, 2008
Emergence of MRSA in positive blood cultures from patients with febrile neutropenia--a cause for concernPatrick G Morris, Tidi Hassan, Mairead McNamara, et al.
Pageof 10